Ryan A. Wilcox
Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
Regents Of The University Of Michigan
1500 E Medical Ctr, Suite 0331, 
Ann Arbor, MI 

Overview

Ryan Wilcox is an Oncologist and a Hematologist in Ann Arbor, Michigan. Dr. Wilcox is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). His top areas of expertise are T-Cell Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Wilcox is currently accepting new patients.

His clinical research consists of co-authoring 102 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL).

Specialties
Oncology
Hematology
Licenses
Internal Medicine in MN
Hospital Affiliations
University Of Michigan Health System
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
EMI Health
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SelectHealth
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 2 Less Insurance Carriers -

Locations

REGENTS OF THE UNIVERSITY OF MICHIGAN
1500 E Medical Ctr, Suite 0331, Ann Arbor, MI 48109
Other Locations
REGENTS OF THE UNIVERSITY OF MICHIGAN
1500 E Medical Ctr Dr, Ann Arbor, MI 48109

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


5 Clinical Trials

Pilot Study of Ruxolitinib in Secondary Hemophagocytic Syndrome
View 4 Less Clinical Trials

102 Total Publications

More than skin deep.
Similar Doctors
Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
Hematology | Oncology
Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
Hematology | Oncology

Regents Of The University Of Michigan

1500 E Medical Ctr Dr, 
Ann Arbor, MI 
 (0.2 miles away)
Languages Spoken:
English, Arabic
Accepting New Patients
Offers Telehealth

Dahlia Sano is a Hematologist and an Oncologist in Ann Arbor, Michigan. Dr. Sano is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). Her top areas of expertise are Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), and Bone Marrow Aspiration. Dr. Sano is currently accepting new patients.

Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
Oncology | Hematology
Distinguished in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
Oncology | Hematology

Henry Ford Health System

2799 W Grand Blvd, 
Detroit, MI 
 (33.6 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Sheela Tejwani is an Oncologist and a Hematologist in Detroit, Michigan. Dr. Tejwani is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). Her top areas of expertise are Adult Soft Tissue Sarcoma, WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, Rhabdomyosarcoma, and Bone Marrow Aspiration. Dr. Tejwani is currently accepting new patients.

Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
Hematology | Hematology Oncology | Oncology
Advanced in Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
Hematology | Hematology Oncology | Oncology

Regents Of The University Of Michigan

1500 E Medical Ctr Dr, 
Ann Arbor, MI 
 (0.2 miles away)
Languages Spoken:
English
Offers Telehealth

Yasmin Karimi is a Hematologist and a Hematologist Oncology provider in Ann Arbor, Michigan. Dr. Karimi is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). Her top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL), and Bone Marrow Aspiration.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wilcox's expertise for a condition
ConditionClose
View All 13 Advanced Conditions
View All 21 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile